ELIQUIS

Product NDC: 0003-3764
11-digit product format: 000033764
Labeler code: 0003
Product ID: 0003-3764_f96cb5ea-74e9-4751-883d-d18ef0d83640
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: apixaban
Dosage form: KIT
Labeler: E.R. Squibb & Sons, L.L.C.
Application: NDA202155
Marketing category: NDA
Marketing start: 2017-11-29
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N202155-001	ELIQUIS	APIXABAN	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28
N202155-002	ELIQUIS	APIXABAN	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28
N202155-003	ELIQUIS	APIXABAN	0.5MG	TABLET, FOR SUSPENSION / ORAL		RLD, RS	2025-04-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N202155-001	AB
N202155-002	AB

Orange Book patents#

Current patent rows page 1 of 1 · 25 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N202155-001	6967208	2026-11-21	U-1167	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1302	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1323	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1501	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1502	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1729	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-1730	Drug substance, Drug product	2013-01-25
N202155-001	6967208	2026-11-21	U-4178	Drug substance, Drug product	2013-01-25
N202155-001	6967208*PED	2027-05-21		Pediatric extension
N202155-001	9326945	2031-02-24		Drug product	2016-05-26
N202155-001	9326945*PED	2031-08-24		Pediatric extension
N202155-002	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25
N202155-002	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25
N202155-002	6967208	2026-11-21	U-1302	Drug substance, Drug product	2013-01-25
N202155-002	6967208	2026-11-21	U-1323	Drug substance, Drug product	2013-01-25
N202155-002	6967208	2026-11-21	U-4178	Drug substance, Drug product	2013-01-25
N202155-002	6967208*PED	2027-05-21		Pediatric extension
N202155-002	9326945	2031-02-24		Drug product	2016-05-26
N202155-002	9326945*PED	2031-08-24		Pediatric extension
N202155-003	6967208	2026-11-21	U-4179	Drug substance, Drug product	2025-05-16
N202155-003	6967208*PED	2027-05-21		Pediatric extension
N202155-003	9326945	2031-02-24		Drug product	2025-05-16
N202155-003	9326945*PED	2031-08-24		Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 6 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N202155-001	NPP	2028-04-17
N202155-001	PED	2028-10-17
N202155-002	NPP	2028-04-17
N202155-002	PED	2028-10-17
N202155-003	NS	2028-04-17
N202155-003	PED	2028-10-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	ELIQUIS	0.5MG	TABLET, FOR SUSPENSION / ORAL		RLD, RS	2025-04-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-003	ELIQUIS	0.5MG	TABLET, FOR SUSPENSION / ORAL		RLD, RS	2025-04-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-003	ELIQUIS	0.5MG	TABLET, FOR SUSPENSION / ORAL		RLD, RS	2025-04-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N202155-002	ELIQUIS	5MG	TABLET / ORAL	AB	RLD, RS	2012-12-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL		RLD	2012-12-28	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N202155-002	ELIQUIS	5MG	TABLET / ORAL		RLD, RS	2012-12-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N202155-001	ELIQUIS	2.5MG	TABLET / ORAL	AB	RLD	2012-12-28	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 74 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N202155-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202155-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202155-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202155-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202155-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202155-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202155-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202155-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202155-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202155-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202155-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202155-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202155-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202155-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N202155-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N202155-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202155-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202155-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202155-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202155-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202155-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202155-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N202155-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N202155-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202155-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202155-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N202155-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N202155-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N202155-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N202155-002	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N202155-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N202155-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N202155-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N202155-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N202155-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N202155-002	AB	1	`87673890dc5c…`

Observed Orange Book patent history#

Patent history page 1 of 18 · 683 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1501	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1302	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1729	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1730	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1167	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-4178	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1323	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208	2026-11-21	U-1502	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	6967208*PED	2027-05-21		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	9326945	2031-02-24		Drug product	2016-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	9326945*PED	2031-08-24		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208	2026-11-21	U-1302	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208	2026-11-21	U-1323	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208	2026-11-21	U-4178	Drug substance, Drug product	2013-01-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	6967208*PED	2027-05-21		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	9326945	2031-02-24		Drug product	2016-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	9326945*PED	2031-08-24		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	6967208	2026-11-21	U-4179	Drug substance, Drug product	2025-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	6967208*PED	2027-05-21		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	9326945	2031-02-24		Drug product	2025-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	9326945*PED	2031-08-24		Pediatric extension		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1501	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1302	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1729	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1730	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1167	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-4178	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1323	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208	2026-11-21	U-1502	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	6967208*PED	2027-05-21		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	9326945	2031-02-24		Drug product	2016-05-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	9326945*PED	2031-08-24		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	6967208	2026-11-21	U-1301	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	6967208	2026-11-21	U-1200	Drug substance, Drug product	2013-01-25	`31067a03dcf5…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N202155-001	NPP	2028-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-001	PED	2028-10-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	NPP	2028-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-002	PED	2028-10-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	NS	2028-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202155-003	PED	2028-10-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	NPP	2028-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-001	PED	2028-10-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	NPP	2028-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-002	PED	2028-10-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-003	NS	2028-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202155-003	PED	2028-10-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202155-001	NPP	2028-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-001	PED	2028-10-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-002	NPP	2028-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-002	PED	2028-10-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-003	NS	2028-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202155-003	PED	2028-10-17	`6a471c1ec25d…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-001	NPP	2028-04-17	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-001	PED	2028-10-17	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-002	NPP	2028-04-17	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-002	PED	2028-10-17	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-003	NS	2028-04-17	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N202155-003	PED	2028-10-17	`a50c72e98297…`

Additional Listing Data#

Finished product: Yes
Brand name base: ELIQUIS
Brand name suffix: 30-Day Starter Pack
Listing expiration: 2027-12-31

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
89fbc7dd-7e16-8a82-0070-9b9487bb8075	Product name	5	20260129

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0003-3764-74	ELIQUIS30-Day Starter Pack	1 in 1 CARTON	KIT	1		30

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0003-3764-74	EA - Each	0003-3764	042982b9-36fb-49a5-8bfe-72af6ec726ce	1	2018-02-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
apixaban	ACTIVE INGREDIENT	3Z9Y7UWC1J	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
apixaban	ACTIVE MOIETY	3Z9Y7UWC1J	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
anhydrous lactose	INACTIVE INGREDIENT	3SY5LH9PMK	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
croscarmellose sodium	INACTIVE INGREDIENT	M28OL1HH48	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7
triacetin	INACTIVE INGREDIENT	XHX3C3X673	ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0003-3764	ELIQUIS (APIXABAN) TABLET, FILM COATED ELIQUIS 30-DAY STARTER PACK (APIXABAN) KIT [E.R. SQUIBB & SONS, L.L.C.]	30	Current NDC, Legacy NDC, 1 package rows	20250504_e9481622-7cc6-418a-acb6-c5450daae9b0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ELIQUIS	APIXABAN	Cardinal Health 107, LLC	a454cd24-0c6d-46e8-b1e4-197388606175	2026-04-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	REMEDYREPACK INC.	7be1f4c1-bb2f-4ded-ae9a-515d2a22f93e	2025-08-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	Aphena Pharma Solutions - Tennessee, LLC	1523ab32-2c2c-6501-e063-6394a90aa0b3	2025-02-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	Aphena Pharma Solutions - Tennessee, LLC	41a133ef-e461-48ad-8221-b735bdd0ec25	2025-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	A-S Medication Solutions	33a9046a-41cc-46c1-becc-2ff4d7d71538	2024-11-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	Proficient Rx LP	33752f5d-2ca7-45c0-8292-b54742219b97	2024-06-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	A-S Medication Solutions	2f47aa0e-0235-4220-85dd-dfcb8ad0d009	2023-05-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155
ELIQUIS	APIXABAN	A-S Medication Solutions	fd383ae7-1e34-44ef-b8f1-ca6906dfbcef	2023-05-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 202155 application number: NDA202155

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3Z9Y7UWC1J	APIXABAN	503612-47-3	apixaban

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1992428	{74 (apixaban 5 MG Oral Tablet [Eliquis]) } Pack [Eliquis 30-Day Starter Pack]	BPCK	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1992427	{74 (apixaban 5 MG Oral Tablet) } Pack	GPCK	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364435	apixaban 2.5 MG Oral Tablet	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1992427	apixaban 30-Day Starter Pack	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364445	apixaban 5 MG Oral Tablet	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364441	Eliquis 2.5 MG Oral Tablet	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1992428	Eliquis 30-Day Starter Pack	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364447	Eliquis 5 MG Oral Tablet	PSN	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364441	apixaban 2.5 MG Oral Tablet [Eliquis]	SBD	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364447	apixaban 5 MG Oral Tablet [Eliquis]	SBD	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364435	apixaban 2.5 MG Oral Tablet	SCD	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364445	apixaban 5 MG Oral Tablet	SCD	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1992427	apixaban 30-Day Starter Pack	SY	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364441	Eliquis 2.5 MG Oral Tablet	SY	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1992428	Eliquis 30-Day Starter Pack	SY	e9481622-7cc6-418a-acb6-c5450daae9b0	30
1364447	Eliquis 5 MG Oral Tablet	SY	e9481622-7cc6-418a-acb6-c5450daae9b0	30

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0003-3764-74	00003376474	1 KIT in 1 CARTON (0003-3764-74) * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK	1 kit	2017-11-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ELIQUIS	E.R. Squibb & Sons, L.L.C. \| Aphena Pharma Solutions - Tennessee LLC	2025-04-17	HUMAN PRESCRIPTION DRUG LABEL	30